IGF2BP2 is a carcinomatous fetal gene that is expressed at lower levels in normal adult tissues than in fetal liver tissues and is overexpressed in various types of cancer, such as glioblastoma, liver cancer, and breast cancer, thus making it a promising therapeutic target in cancer (Hammer et al., 2005; Weng et al., 2022). The gene discussed is IGF2BP2; the disease is liver cancer.